Dr. Brian W. Loggie, MD, Professor of Surgery at Creighton University Medical School in Omaha, Nebraska, is an expert in the field of surgical oncology. In addition to his professorship, Loggie also serves as the Chief of the Division of Surgical Oncology at Creighton University Medical Center and as the director of the Cancer Biology Program at the hospital.

Loggie received his undergraduate degree in pre-med from Loyola College in Montreal, Canada in 1974 and earned his medical degree in 1979 from McGill University, also in Montreal. His post-graduate training included an internship with the Department of Surgery at Montreal General Hospital in Montreal and a residency at the same hospital. He was also involved in Graduate Studies with the Department of Experimental Surgery at McGill University from 1982 to 1986.

In addition, Dr. Loggie was a research fellow at the University of Illinois in Chicago in the division of Surgical Oncology Department of Surgery. He also received a Specialist Certificate in General Surgery from the Royal College of Physicians and Surgeons of Canada in 1986.

Dr. Loggie lists his specialty and area of interest as surgical oncology, in particular the treatment and study of peritoneal carcinomatosis and malignant ascites, peritoneal mesothelioma, abdominopelvic and retroperitoneal sarcomas, pseudomyxoma peritonei, cutaneous malignant melanoma, sphincter preserving treatment for rectal tumors, and management of complex primary or recurrent solid tumors. His expertise in these areas has made him one of the top doctors to be considered for the treatment of rare peritoneal mesothelioma.

In the early 1990s, while at Wake Forest University Baptist Medical Center, Dr. Loggie developed a cutting-edge cancer treatment that combined surgery with the application of heated chemotherapy drugs directly into the abdominal cavity. The heat makes the chemotherapy drug more effective in penetrating and killing off cancer cells. The procedure is now widely used to treat various kinds of cancer.

Dr. Loggie belongs to numerous medical societies and organizations including the Society of Surgical Oncology; the American College of Surgeons, Canadian Association of General Surgeons, the Association for Academic Surgery, the American Medical Association, the Cancer and Leukemia Group B(CALGB), American College of Surgeons, American Society of Clinical Oncology (ASCO), the International Society for Regional Cancer Therapy, Medical Research Council of Canada and many others.

In addition, Loggie has authored or co-authored a variety of articles and papers, many that have dealt with the research and treatment of peritoneal mesothelioma.

Contact Information:
Dr. Brian W. Loggie
Creighton University Medical Center
601 North 30th Street, Suite 2803
Omaha, NE 68131
(402) 280-4100

Doctor Match Program

One of the most important factors in improving a mesothelioma patient's life expectancy is their selection of doctor and treatment facility. Asbestos.com's Doctor Match Program is now helping patients get matched with top mesothelioma specialists around the country. If you wish to take advantage of this free service please call us at (800) 549-0544 or click here visit our doctor match page.

Two must read books for anyone who has or who is caring for someone with mesothelioma.

Get a Free Copy of Lean on Me or 100 Questions & Answers About Mesothelioma.

Asbestos.com has experienced navy veterans on staff to assist veterans in answering questions about applying for asbestos-related VA Claims and other benefits.

*Asbestos.com is not affiliated with the
U.S. Department. of Veterans Affairs.

Naval Ships Index
Search through our extensive list of ships that used asbestos-containing products.
(e.g. USS Alabama BB 60)

Get matched with the top mesothelioma specialists in your area.

Learn what foods to eat, which to avoid, and the best supplements for the fight against cancer and chemotherapy recovery.

Pleural Mesothelioma May Have New Biomarker
09/01/2010 - In a recent article published in the online publication Modern Pathology, researchers may have found a new biomarker for malignant pleural mesotheliom..
Mesothelioma-Causing Asbestos May be Banned in Taiwan
08/31/2010 - According to a news report, Taiwan's Environmental Protection Agency (EPA) has plans to phase out the use of asbestos within the next decade. Lin C..
Mesothelioma Risk in Schools Can Be Managed
08/30/2010 - Seven schools in Virginia Beach, Virginia built between 1956 and 1974 have been found to contain a small amount of asbestos in sealants applied to the..